# Berkley W R Corp: financial statements, quarterly

WRB · NYSE · CIK 11544 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wrb.md) · [Financials](/companies/wrb/financials.md) · [Filings](/companies/wrb/filings.md) · [Insiders](/companies/wrb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wrb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,031](/filings/0000011544-24-000028.md) | [3,221 d](/filings/0000011544-26-000005.md) | [3,257](/filings/0000011544-25-000009.md) | [3,314](/filings/0000011544-25-000024.md) | [3,400](/filings/0000011544-25-000032.md) | [3,668 d](/filings/0000011544-26-000005.md) | [3,547](/filings/0000011544-26-000011.md) | [3,671](/filings/0000011544-26-000036.md) | [3,768](/filings/0000011544-25-000032.md) | [3,721 d](/filings/0000011544-26-000005.md) | [3,690](/filings/0000011544-26-000011.md) | [3,716](/filings/0000011544-26-000036.md) |
| Interest expense | $m | [31.9](/filings/0000011544-24-000028.md) | [31.9 d](/filings/0000011544-26-000005.md) | [31.7](/filings/0000011544-25-000009.md) | [31.7](/filings/0000011544-25-000024.md) | [31.7](/filings/0000011544-25-000032.md) | [31.8 d](/filings/0000011544-26-000005.md) | [31.7](/filings/0000011544-26-000011.md) | [31.8](/filings/0000011544-26-000036.md) | [31.8](/filings/0000011544-25-000032.md) | [31.6 d](/filings/0000011544-26-000005.md) | [31.7](/filings/0000011544-26-000011.md) | [31.7](/filings/0000011544-26-000036.md) |
| Income tax | $m | [86.5](/filings/0000011544-24-000028.md) | [102 d](/filings/0000011544-26-000005.md) | [132](/filings/0000011544-25-000009.md) | [116](/filings/0000011544-25-000024.md) | [109](/filings/0000011544-25-000032.md) | [153 d](/filings/0000011544-26-000005.md) | [121](/filings/0000011544-26-000011.md) | [121](/filings/0000011544-26-000036.md) | [136](/filings/0000011544-25-000032.md) | [117 d](/filings/0000011544-26-000005.md) | [101](/filings/0000011544-26-000011.md) | [123](/filings/0000011544-26-000036.md) |
| Net income | $m | [334](/filings/0000011544-24-000028.md) | [397 d](/filings/0000011544-26-000005.md) | [442](/filings/0000011544-25-000009.md) | [372](/filings/0000011544-25-000024.md) | [366](/filings/0000011544-25-000032.md) | [576 d](/filings/0000011544-26-000005.md) | [418](/filings/0000011544-26-000011.md) | [401](/filings/0000011544-26-000036.md) | [511](/filings/0000011544-25-000032.md) | [450 d](/filings/0000011544-26-000005.md) | [515](/filings/0000011544-26-000011.md) | [452](/filings/0000011544-26-000036.md) |
| Diluted EPS | $ per share | [0.82](/filings/0000011544-24-000028.md) | not reported | [1.09](/filings/0000011544-25-000009.md) | [0.92](/filings/0000011544-25-000024.md) | [0.91](/filings/0000011544-25-000032.md) | not reported | [1.04](/filings/0000011544-26-000011.md) | [1.00](/filings/0000011544-26-000036.md) | [1.28](/filings/0000011544-25-000032.md) | not reported | [1.31](/filings/0000011544-26-000011.md) | [1.15](/filings/0000011544-26-000036.md) |
| Basic EPS | $ per share | [0.83](/filings/0000011544-24-000028.md) | not reported | [1.10](/filings/0000011544-25-000009.md) | [0.93](/filings/0000011544-25-000024.md) | [0.92](/filings/0000011544-25-000032.md) | not reported | [1.05](/filings/0000011544-26-000011.md) | [1.01](/filings/0000011544-26-000036.md) | [1.29](/filings/0000011544-25-000032.md) | not reported | [1.31](/filings/0000011544-26-000011.md) | [1.16](/filings/0000011544-26-000036.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.6](/filings/0000011544-23-000023.md) | [1.4](/filings/0000011544-25-000005.md) | [1.2](/filings/0000011544-24-000012.md) | [1.6](/filings/0000011544-24-000024.md) | [1.6](/filings/0000011544-24-000028.md) | [2.0](/filings/0000011544-26-000005.md) | [1.7](/filings/0000011544-25-000009.md) | [2.0](/filings/0000011544-25-000024.md) | [2.4](/filings/0000011544-25-000032.md) | [2.5](/filings/0000011544-26-000036.md) | [2.3](/filings/0000011544-26-000011.md) | [2.6](/filings/0000011544-26-000036.md) |
| Total assets | $bn | [36.1](/filings/0000011544-23-000023.md) | [37.2](/filings/0000011544-25-000005.md) | [37.9](/filings/0000011544-24-000012.md) | [38.9](/filings/0000011544-24-000024.md) | [40.4](/filings/0000011544-24-000028.md) | [40.6](/filings/0000011544-26-000005.md) | [41.3](/filings/0000011544-25-000009.md) | [42.7](/filings/0000011544-25-000024.md) | [43.7](/filings/0000011544-25-000032.md) | [43.9](/filings/0000011544-26-000036.md) | [44.3](/filings/0000011544-26-000011.md) | [45.7](/filings/0000011544-26-000036.md) |
| Total liabilities | $bn | [29.2](/filings/0000011544-23-000023.md) | [29.7](/filings/0000011544-25-000005.md) | [30.1](/filings/0000011544-24-000012.md) | [31.1](/filings/0000011544-24-000024.md) | [31.9](/filings/0000011544-24-000028.md) | [32.2](/filings/0000011544-26-000005.md) | [32.4](/filings/0000011544-25-000009.md) | [33.4](/filings/0000011544-25-000024.md) | [33.9](/filings/0000011544-25-000032.md) | [34.2](/filings/0000011544-26-000036.md) | [34.6](/filings/0000011544-26-000011.md) | [35.8](/filings/0000011544-26-000036.md) |
| Shareholders' equity | $bn | [6.9](/filings/0000011544-23-000023.md) | [7.5](/filings/0000011544-25-000005.md) | [7.8](/filings/0000011544-24-000012.md) | [7.8](/filings/0000011544-24-000024.md) | [8.4](/filings/0000011544-24-000028.md) | [8.4](/filings/0000011544-26-000005.md) | [8.9](/filings/0000011544-25-000009.md) | [9.3](/filings/0000011544-25-000024.md) | [9.8](/filings/0000011544-25-000032.md) | [9.7](/filings/0000011544-26-000036.md) | [9.7](/filings/0000011544-26-000011.md) | [9.8](/filings/0000011544-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,077 d](/filings/0000011544-24-000028.md) | [698 d](/filings/0000011544-26-000005.md) | [746](/filings/0000011544-25-000009.md) | [881 d](/filings/0000011544-25-000024.md) | [1,241 d](/filings/0000011544-25-000032.md) | [810 d](/filings/0000011544-26-000005.md) | [744](/filings/0000011544-26-000011.md) | [704 d](/filings/0000011544-26-000036.md) | [1,140 d](/filings/0000011544-25-000032.md) | [995 d](/filings/0000011544-26-000005.md) | [668](/filings/0000011544-26-000011.md) | [800 d](/filings/0000011544-26-000036.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [0.0 d](/filings/0000011544-24-000028.md) | [315 d](/filings/0000011544-26-000005.md) | [28.2](/filings/0000011544-25-000009.md) | [158 d](/filings/0000011544-25-000024.md) | [126 d](/filings/0000011544-25-000032.md) | [220 d](/filings/0000011544-26-000005.md) | [30.3](/filings/0000011544-26-000011.md) | [224 d](/filings/0000011544-26-000036.md) | [34.2 d](/filings/0000011544-25-000032.md) | [412 d](/filings/0000011544-26-000005.md) | [33.7](/filings/0000011544-26-000011.md) | [0.0 d](/filings/0000011544-26-000036.md) |
| Share repurchases | $m | [2.9 d](/filings/0000011544-24-000028.md) | [107 d](/filings/0000011544-26-000005.md) | [0.0](/filings/0000011544-25-000009.md) | [224 d](/filings/0000011544-25-000024.md) | [12.5 d](/filings/0000011544-25-000032.md) | [67.4 d](/filings/0000011544-26-000005.md) | [49.2](/filings/0000011544-26-000011.md) | [0.0 d](/filings/0000011544-26-000036.md) | [24.6 d](/filings/0000011544-25-000032.md) | [196 d](/filings/0000011544-26-000005.md) | [302](/filings/0000011544-26-000011.md) | [111 d](/filings/0000011544-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [280](/filings/0000011544-23-000023.md) | [277](/filings/0000011544-24-000012.md) | [410](/filings/0000011544-24-000024.md) | [407](/filings/0000011544-24-000028.md) | [406](/filings/0000011544-25-000009.md) | [404](/filings/0000011544-25-000024.md) | [402](/filings/0000011544-25-000032.md) | [400](/filings/0000011544-26-000011.md) | [400](/filings/0000011544-26-000036.md) | [400](/filings/0000011544-25-000032.md) | [395](/filings/0000011544-26-000011.md) | [392](/filings/0000011544-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 371,227,529 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0000011544-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.